44 2033180199
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Journal of Experimental and Clinical Microbiology

Sign up for email alert when new content gets added: Sign up

Fungal coinfections in COVID-19 patients – current evidence and future directions

Author(s): Gouthami Jajapuram*, Subhadra Polisetti, Venugopal Madhusudhana and Vinay Kumar Pandey

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for the ongoing pandemic named coronavirus disease (COVID-19). COVID-19 patients, especially those who are severely ill or immunosuppressed, are more prone to invasive fungal infections. Early detection is mandatory in COVID-19 patients with invasive mycoses, which can be done through comprehensive diagnostic intervention to ensure effective treatment. In this review, we have discussed the importance of evaluating coinfections associated with COVID 19, the types of invasive mycoses, different methods of diagnosis, clinical settings, and the importance of standard treatment in patients with COVID-19. The current article aims to help clinicians manage aspergillosis, candidiasis, mucormycosis, and cryptococcosis in patients with COVID-19.

Google Scholar citation report
Citations : 46

Journal of Experimental and Clinical Microbiology received 46 citations as per Google Scholar report